Pacira BioSciences, Inc.
Market Cap
$943.89M
P/E Ratio
137.13
EPS
$0.16
Dividend Yield
0.00%
52-Week Range
$18.80 — $27.64
Volume
866.36K
Avg Volume
913.14K
Beta
0.23
P/E (TTM)
137.13
Forward P/E
6.44
PEG Ratio
-2.11
P/S (TTM)
1.39
P/B (TTM)
1.44
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.01%
ROA (TTM)
0.01%
ROIC
—
Gross Margin
0.77%
Operating Margin
0.03%
Net Margin
—
Debt/Equity
0.66
Current Ratio
4.54
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.80%
EPS Growth (5Y)
+2.10%
Sales Growth (3Y)
+0.09%
Sales Growth (5Y)
+0.11%
EPS Est (This Year)
$3.41
EPS Est (Next Year)
$3.85
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$5.61
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
43.02M
Float
42.15M
Free Float %
97.98%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
NASDAQ
IPO Date
2011-02-03
Employees
788
CEO
Frank D. Lee
Index Membership
—
Website
https://www.pacira.com
Pacira BioSciences, Inc. (PCRX) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $943.89M, a P/E ratio of 137.13, PCRX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PCRX against other stocks using dozens of fundamental and technical filters.
Pacira BioSciences, Inc. (PCRX) has a trailing twelve-month (TTM) P/E ratio of 137.13. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Pacira BioSciences, Inc. (PCRX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Pacira BioSciences, Inc. (PCRX) has a market capitalization of $943.89 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.